Overview of Transaction

• On July 23, 2025, Accelerant announced the pricing of its upsized IPO at $21 per share, raising $724 million in gross proceeds
• The IPO priced above the initial filing range of $18 – 20 and the offering consisted of 20,276,280 common shares offered by Accelerant and 14,184,872 common shares offered by certain existing shareholders of the Company
• Underwriters have a 30-day option to purchase up to an additional 5,169,172 common shares from certain selling shareholders
• The common shares began trading on July 24, 2025, on the New York Stock Exchange under the ticker symbol “ARX”
• Founded in 2018, Accelerant is a data-driven risk exchange connecting underwriters of specialty insurance risk with risk capital providers
• The Accelerant risk exchange does business across 22 different countries and more than 500 specialty insurance products

Significance of Transaction

• The IPO represents the largest US InsurTech IPO since 2021
• Accelerant expects to use net proceeds from this offering to fund the redemption of its Class C convertible preference shares, for a one-time termination fee to an affiliate of Altamont Capital, with the remainder going towards general corporate purposes, such as purchasing products, services, or technologies, or acquiring or investing in MGAs, insurance intermediaries, insurance companies, technology companies, and service providers in Accelerant’s ecosystem

FT Partners' Role

• FT Partners served as co-manager on this IPO
• FT Partners previously served as financial and strategic advisor to Accelerant on its $193 million capital raise led by Eldridge at a $2 billion valuation in 2022
• This transaction highlights FT Partners’ deep domain expertise in the InsurTech space, as well as our capabilities in helping companies navigate the IPO process